Oregonians Approve Measure to Legalize Psilocybin Therapy

November 9, 2020 10:54:15

Voters in Oregon have approved a psilocybin ballot initiative, with 1,193,632 people voting yes on the measure and 947,650 individuals voting no. The initiative legalizes psilocybin mushroom use for therapeutic purposes.

Under the initiative, adults will be able to acquire psychedelic treatment in an environment that is medically supervised. The measure has no limitations on the conditions required for an individual to be eligible for treatment. Presently, no policies such as this exist in any other state in the United States, although the victory does come at a time when a national movement calling for the decriminalization of various entheogenic substances, including ibogaine and ayahuasca, is growing. Cities such as Ann ArborSanta Cruz and Oakland have passed legislation making fungi and plant-derived psychedelics low-enforcement priorities.

Over in Washington, DC, voters also approved a ballot measure to pass the same policy change. In the U.S., the first city to decriminalize psilocybin mushrooms was Denver, in 2019.

Regulators in Oregon will also be in charge of issuing licenses for the manufacturing, testing and administering of psilocybin mushrooms by January 2, 2023. The campaign that organized the psilocybin reform measure gained a lot from the ads they ran to promote their efforts.

For instance, in a TV ad released last month for the campaign, a medical doctor stated that the initiative could help alleviate the mental suffering for people who were terminally ill. A prior ad had featured a medical doctor, who also happened to be a state senator, stating that the proposal promoted the safety of a therapy that can help individuals who are suffering. This seems to have worked in sensitizing people and making it known to them the various benefits of this psychedelic substance.

Last week, Oregon also approved a separate proposal to broaden substance misuse treatment and decriminalize drug possession for small amounts of drugs such as cocaine, heroin and methamphetamine. The advocates behind that campaign had also released ads on the project. The Oregon Democratic Party formally seconded both initiatives last month.

This does not mean that the proposed legislation had no opposition. The psychedelic reform measure drew opposition from a rather unlikely body. Decriminalize Nature, which has been behind various campaigns in different states to decrease criminal enforcement again entheogens such as psilocybin, argued that the decriminalization of the hallucinogenic mushrooms would threaten access to the psychedelic.

Earlier in January, Rep. Earl Blumenauer stated in an interview that not only was he all for the psilocybin reform proposal but that he would also boost the campaign as the election drew near. He added in an email blast in August that passing the initiative was necessary because the measure tackled mental health, an important issue in the community, in a responsible and innovative way.

Cybin Corp. is a psychedelics company you should watch. This Canada-based entity specializes in developing therapeutic products from psychedelics and also has an interest in the functional mushroom market.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.